Lista de obras - Leon A. Bach - Dominio Público Uruguay

1H, 13C and 15N resonance assignments of the C-terminal domain of insulin-like growth factor binding protein-6 (IGFBP-6)

scientific article published on 01 March 2003

A case of mucormycosis limited to the parotid gland.

artículo científico publicado en 2005

Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner.

artículo científico publicado en 2005

Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models

artículo científico publicado en 2012

Advanced glycation end‐products induce calpain‐mediated degradation of ezrin ⬇️

artículo científico publicado el 3 de agosto de 2012

An unexpectedly high prevalence of undiagnosed diabetes in patients awaiting lung transplantation

artículo científico publicado en 2013

Association of a nicotinic receptor mutation with reduced height and blunted physostigmine-stimulated growth hormone release

artículo científico publicado en 2007

Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.

artículo científico publicado en 2004

Blogging during terminal care: communication, color schemes, and creating a community

artículo científico publicado en 2008

C-terminal domain of insulin-like growth factor (IGF) binding protein 6: conformational exchange and its correlation with IGF-II binding

scientific article published on 01 September 2004

C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II

scientific journal article

Clinical, psychological and demographic factors in a contemporary adult cohort with diabetic ketoacidosis and type 1 diabetes

scientific article published on 02 May 2020

Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.

artículo científico publicado en 2004

Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding

artículo científico publicado en 2007

Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration.

artículo científico publicado en 2010

Diabetes Is a Major Risk Factor for Mortality After Lung Transplantation

artículo científico publicado en 2014

Diabetes-related renal growth and IGF-I accumulation in castrated rats

artículo científico publicado en 1991

Diabetic Nephropathy: Do Cannabinoids Contribute? ⬇️

artículo científico publicado el 1 de marzo de 2012

Differential Effects of Insulin-Like Growth Factor Binding Protein-6 (IGFBP-6) on Migration of Two Ovarian Cancer Cell Lines

artículo científico publicado en 2014

Endothelial cells and the IGF system

artículo científico publicado en 2015

Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye.

artículo científico publicado en 2005

Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products.

artículo científico publicado en 2015

Fibroblast growth factor-2 over-rides insulin-like growth factor-I induced proliferation and cell survival in human neuroblastoma cells.

artículo científico publicado en 2004

Glomerular filtration rate in early experimental diabetes

artículo científico publicado en 1988

Human insulin-like growth factor binding protein-6 is O-glycosylated

artículo científico publicado en 1992

IGF binding protein‐6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis ⬇️

artículo científico publicado el 5 de agosto de 2011

IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease ⬇️

artículo científico publicado el 24 de abril de 2013

IGF-binding proteins--the pieces are falling into place.

artículo científico publicado en 2005

IGFBP-6 five years on; not so 'forgotten'?

artículo científico publicado en 2005

Identification of O-Glycosylation Sites and Partial Characterization of Carbohydrate Structure and Disulfide Linkages of Human Insulin-like Growth Factor Binding Protein 6 ⬇️

artículo científico publicado el 5 de mayo de 1998

Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system

artículo científico publicado en 2000

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes

artículo científico publicado en 1999

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway

scientific journal article

Inhibition of Plasmodium falciparum CDPK1 by conditional expression of its J-domain demonstrates a key role in schizont development

artículo científico publicado en 2013

Insulin-Like Growth Factor Binding Protein-2 Binds to Cell Surface Proteoglycans in the Rat Brain Olfactory Bulb* ⬇️

artículo científico publicado el 1 de noviembre de 1997

Insulin-like growth factor binding protein-6 and CCI-779, an ester analogue of rapamycin, additively inhibit rhabdomyosarcoma growth.

artículo científico publicado en 2003

Insulin-like growth factor binding proteins 4-6.

artículo científico publicado en 2015

Insulin-like growth factor-binding protein-6 and cancer.

artículo científico

Insulin-like growth factors and kidney disease

artículo científico publicado en 2014

Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.

artículo científico publicado en 2007

Localization of the ezrin binding epitope for advanced glycation endproducts

scientific article published on 07 December 2007

Making sense of newer treatment options for type 2 diabetes

scientific article published on 01 July 2018

Measurement of insulin-like growth factor (IGF)-II binding to purified IGF binding proteins 1-6: comparison of charcoal adsorption and high performance size exclusion chromatography

artículo científico publicado en 1996

O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis

scientific journal article

Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo

artículo científico publicado en 2001

Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222.

artículo científico publicado en 2015

Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.

artículo científico publicado en 2010

Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study.

artículo científico publicado en 2014

Prevalence of hyperglycaemia without previously recognised diabetes mellitus in the Emergency Department and subsequent management - A retrospective cross-sectional study

scientific article published on 16 December 2019

Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration

artículo científico publicado en 2013

Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6

scientific article published on 22 May 2007

Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy

artículo científico publicado en 2000

Recent insights into the actions of IGFBP-6.

artículo científico publicado en 2015

Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts ⬇️

artículo científico publicado el 1 de noviembre de 1994

Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution.

artículo científico publicado en 2009

Regulation of IGF-binding protein-6 by dexamethasone and IGFs in PC12 rat phaeochromocytoma cells

artículo científico publicado en 1997

Stereotactic radiosurgery for treatment of Cushing disease: an Australian experience

artículo científico publicado en 2012

Structure, dynamics and heparin binding of the C-terminal domain of insulin-like growth factor-binding protein-2 (IGFBP-2)

artículo científico publicado en 2006

Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content

artículo científico publicado en 2013

The N-terminal disulfide linkages of human insulin-like growth factor-binding protein-6 (hIGFBP-6) and hIGFBP-1 are different as determined by mass spectrometry

artículo científico publicado en 1999

The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs

artículo científico publicado en 2007

The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications.

artículo científico publicado en 2003

The high burden of inpatient diabetes mellitus: the Melbourne Public Hospitals Diabetes Inpatient Audit.

artículo científico publicado en 2014

The insulin-like growth factor system in kidney disease and hypertension.

artículo científico

Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis

artículo científico publicado en 2013

Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.

artículo científico publicado en 2003

Lista de obras de Leon A. Bach

1H, 13C and 15N resonance assignments of the C-terminal domain of insulin-like growth factor binding protein-6 (IGFBP-6)

A case of mucormycosis limited to the parotid gland.

Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner.

Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models

Advanced glycation end‐products induce calpain‐mediated degradation of ezrin ⬇️

An unexpectedly high prevalence of undiagnosed diabetes in patients awaiting lung transplantation

Association of a nicotinic receptor mutation with reduced height and blunted physostigmine-stimulated growth hormone release

Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.

Blogging during terminal care: communication, color schemes, and creating a community

C-terminal domain of insulin-like growth factor (IGF) binding protein 6: conformational exchange and its correlation with IGF-II binding

C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II

Clinical, psychological and demographic factors in a contemporary adult cohort with diabetic ketoacidosis and type 1 diabetes

Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.

Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding

Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration.

Diabetes Is a Major Risk Factor for Mortality After Lung Transplantation

Diabetes-related renal growth and IGF-I accumulation in castrated rats

Diabetic Nephropathy: Do Cannabinoids Contribute? ⬇️

Differential Effects of Insulin-Like Growth Factor Binding Protein-6 (IGFBP-6) on Migration of Two Ovarian Cancer Cell Lines

Endothelial cells and the IGF system

Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye.

Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products.

Fibroblast growth factor-2 over-rides insulin-like growth factor-I induced proliferation and cell survival in human neuroblastoma cells.

Glomerular filtration rate in early experimental diabetes

Human insulin-like growth factor binding protein-6 is O-glycosylated

IGF binding protein‐6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis ⬇️

IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease ⬇️

IGF-binding proteins--the pieces are falling into place.

IGFBP-6 five years on; not so 'forgotten'?

Identification of O-Glycosylation Sites and Partial Characterization of Carbohydrate Structure and Disulfide Linkages of Human Insulin-like Growth Factor Binding Protein 6 ⬇️

Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway

Inhibition of Plasmodium falciparum CDPK1 by conditional expression of its J-domain demonstrates a key role in schizont development

Insulin-Like Growth Factor Binding Protein-2 Binds to Cell Surface Proteoglycans in the Rat Brain Olfactory Bulb* ⬇️

Insulin-like growth factor binding protein-6 and CCI-779, an ester analogue of rapamycin, additively inhibit rhabdomyosarcoma growth.

Insulin-like growth factor binding proteins 4-6.

Insulin-like growth factor-binding protein-6 and cancer.

Insulin-like growth factors and kidney disease

Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.

Localization of the ezrin binding epitope for advanced glycation endproducts

Making sense of newer treatment options for type 2 diabetes

Measurement of insulin-like growth factor (IGF)-II binding to purified IGF binding proteins 1-6: comparison of charcoal adsorption and high performance size exclusion chromatography

O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis

Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo

Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222.

Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.

Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study.

Prevalence of hyperglycaemia without previously recognised diabetes mellitus in the Emergency Department and subsequent management - A retrospective cross-sectional study

Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration

Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6

Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy

Recent insights into the actions of IGFBP-6.

Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts ⬇️

Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution.

Regulation of IGF-binding protein-6 by dexamethasone and IGFs in PC12 rat phaeochromocytoma cells

Stereotactic radiosurgery for treatment of Cushing disease: an Australian experience

Structure, dynamics and heparin binding of the C-terminal domain of insulin-like growth factor-binding protein-2 (IGFBP-2)

Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content

The N-terminal disulfide linkages of human insulin-like growth factor-binding protein-6 (hIGFBP-6) and hIGFBP-1 are different as determined by mass spectrometry

The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs

The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications.

The high burden of inpatient diabetes mellitus: the Melbourne Public Hospitals Diabetes Inpatient Audit.

The insulin-like growth factor system in kidney disease and hypertension.

Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis

Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.